Pharma

Your Article Summary

See Latest Articles

Enzon Reports Third Quarter Results
Enzon Pharmaceuticals, 11/04/09

Enzon Pharmaceuticals, Inc. announced its third quarter 2009 financial results. For the three months ended September 30, 2009, Enzon reported a net income of $0.1 million or break–even on a diluted per–share basis, as compared to a net loss of $2.0 million or $0.05 on a diluted per–share basis for the third quarter of 2008. In the third quarter of 2009, the Products segment profitability grew 55% as compared to the third quarter of 2008.

Today in Financial Reports...keeping you current

Receive free subspecialty "5-minute updates" via email

HP to Acquire Networking Firm 3Com
HealthDataManagement, 11/20/09

Protox Reports 2009 Third Quarter Results
Protox Therapeutics , 11/18/09

King Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference
King Pharmaceuticals, 11/16/09

 See all of Financial Reports